The Board NIOX Group Plc recommending the payment of a final dividend for FY23 of 1 pence per share. Going forward, the Board intends to pursue a progressive dividend policy, growing future dividends in line with earnings.
Other financial highlights include:
Revenue growth of 18% to £36.8 million (2022: £31.3 million) and 22% on a constant currency basis
Clinical revenue growth of 24% (29% on a constant currency basis) to £32.6 million (2022: £26.2 million)
Group adjusted EBITDA of £11.4 million, in line with upgraded consensus estimates (2022: £7.3 million)
Net cash £19.9 million (31 December 2022: £19.4 million)
A special dividend of 2.5 pence per share (equating to a return of cash of £10.5 million) was paid to shareholders on 15 September 2023
